ARCH Venture Partners VII, L.P.'s Net Worth

$672 Million

Estimate Recalculated Feb 16, 2024 04:32PM EST

Who is ARCH Venture Partners VII, L.P.?

ARCH Venture Partners VII, L.P. has an estimated net worth of $672 Million. This is based on reported shares across multiple companies, which include PHASERX, INC., AGIOS PHARMACEUTICALS INC, Neumora Therapeutics, Inc., Receptos, Inc., 908 Devices Inc., Pulmatrix, Inc., bluebird bio, Inc., Twist Bioscience Corp, Sage Therapeutics, Inc., Unity Biotechnology, Inc., Syros Pharmaceuticals, Inc., and Juno Therapeutics, Inc..

SEC CIK

ARCH Venture Partners VII, L.P.'s CIK is 0001544444

Past Insider Trading and Trends

2018 was ARCH Venture Partners VII, L.P.'s most active year for acquiring shares with 15 total transactions. ARCH Venture Partners VII, L.P.'s most active month to acquire stocks was the month of April. 2014 was ARCH Venture Partners VII, L.P.'s most active year for disposing of shares, totalling 13 transactions. ARCH Venture Partners VII, L.P.'s most active month to dispose stocks was the month of April. 2023 saw ARCH Venture Partners VII, L.P. paying a total of $25,500,000.00 for 18,924,704 shares, this is the most they've acquired in one year. In 2014 ARCH Venture Partners VII, L.P. cashed out on 24,272,413 shares for a total of $1,345,906.01, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PHASERX, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+12.62%
319.94K
$2.51
$4,993,199.41
2.85M
May 23
Form 3/A
0
0
Form 3
0
0
No matching records found

AGIOS PHARMACEUTICALS INC (AGIO) Snapshot price: $23.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-11.11%
-386.07K
3.09M
Feb 19
Form 4
-10.00%
-386.07K
3.47M
Jun 23
Form 4
3.86M
3.86M
Jul 29
Form 3
0
0
No matching records found

Receptos, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.03%
-45.38K
$29.66
-$1,345,906.01
2.19M
May 13 - May 14
Form 4
+1,852.25%
2.12M
$14.00
2.23M
May 14
Form 3
0
0
No matching records found

Pulmatrix, Inc. (PULM) Snapshot price: $1.8

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
+50.30%
1.15M
3.44M
Apr 3
Form 4/A
0
0
Jun 15
Form 4
2.29M
$6.88
2.29M
Jun 15 - Jun 16
Form 3
0
0
No matching records found

bluebird bio, Inc. (BLUE) Snapshot price: $0.93305

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.79M
1.79M
Jun 24
Form 3
0
0
No matching records found